p53 nuclear accumulation and multiploidy are adverse prognostic factors in surgically resected stage II colorectal cancers independent of fluorouracil-based adjuvant therapy

American Journal of Clinical Pathology

Volumn 116, Issue 3, 2001, Pages 360-368

  Buglioni, S ^a   D'Agnano, I ^a   Vasselli, S ^a   Donnorso, R P ^a   D'Angelo, C ^a   Brenna, A ^a   Benevolo, M ^a   Cosimelli, M ^a   Zupi, G ^a   Mottolese, M ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Colorectal cancer; DNA multiploidy; P53; Prognosis

Indexed keywords

FLUOROURACIL; FOLINIC ACID; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DO7; NUCLEAR PROTEIN; POLYCLONAL ANTIBODY; POLYCLONAL ANTIBODY CM1; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DNA CONTENT; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROGNOSIS;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC AGENTS; CELL NUCLEUS; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; FLUOROURACIL; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYPLOIDY; SURVIVAL ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 17944365210     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/V7UW-UT2E-JVYH-DGWK     Document Type: Article

References (32)

1. Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer
2. Near diploid large bowel carcinomas have better five-year survival than aneuploid ones
3. Prognostic significance of DNA ploidy in patients with stage II and stage III colon carcinoma: A prospective flow cytometric study
4. Prognostic influence of p53 nuclear overexpression in colorectal carcinoma
5. Bc1-2 protein expression: Association with p53 and prognosis in colorectal cancer
6. p53 Tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma
7. Prognostic factors in colorectal cancer
8. Five-year prospective study of DNA tumor ploidy and colorectal cancer survival
9. Prognostic significance of p53 expression, chromosome 17 copy number, and DNA ploidy in non metastasized colorectal carcinomas
10. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer
11. The role of multiploidy as unfavourable prognostic variable in colorectal cancer
12. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and Bc1-2
13. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma
14. Cytoplasmic accumulation of p53 protein: An independent prognostic indicator in colorectal adenocarcinomas
15. Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer: An immunohistochemical analysis
16. Prognostic significance of p53 nuclear and cytoplasmic overexpression in right and left colorectal adenocarcinomas
17. Evaluation of four antibodies in detecting p53 protein for predicting clinicopathological and prognostic significance in colorectal adenocarcinoma
18. Flow cytometric analysis of ploidy in colorectal cancer: A multicentric experience
19. DNA ploidy, cell kinetics, epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer
20. Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer
21. Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas
22. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms
23. The TP53 tumour suppressor gene in colorectal carcinomas, II: Relation to DNA ploidy pattern and clinicopathological variables
24. Allelic loss of chromosome 18q and prognosis in colorectal cancer
25. Multiple genetic alterations in distal and proximal colorectal cancer
26. p53 and behaviour of colorectal cancer
27. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: Impact on survival of 388 patients with Dukes' C colon carcinoma
28. Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients
29. Adjuvant chemotherapy in colorectal cancer with high-dose leucovorin and fluorouracil: Impact on disease-free survival and overall survival
30. A phase I trial of 5-day chronomodulated infusion of 5-fluorouracil and 1-folinic acid in patients with metastatic colorectal cancer
31. Randomised multicentre trial of chronotherapy with oxaliplatin, fluorouracil, and folinic acid in metastatic colorectal cancer
32. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers